Ho Sung Jeon

Ho Sung Jeon

Auto-generated profile, based on publicly available information

Ho Sung Jeon

Division of Cardiology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2024 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
JLJung-Hee Lee
Jung-Hee Lee
SASung Gyun Ahn
Sung Gyun Ahn
HJHo Sung Jeon
Ho Sung Jeon
YYYoung Jin Youn
Young Jin Youn
YLYong-Joon Lee
Yong-Joon Lee
BKByeong-Keuk Kim
Byeong-Keuk Kim

31 January 2009 in Journal of the Korean Society of Food Science and Nutrition
Verified
Journal Article
Closed access
HJHo-Sung Jeon
Ho-Sung Jeon
YLYang-Suk Lee
Yang-Suk Lee
NKNam-Woo Kim
Nam-Woo Kim

1 October 2025 in JACC: Advances
Verified
Journal Article
Open access
JLJun-Won Lee
Jun-Won Lee
CKChan Joon Kim
Chan Joon Kim
BLBong-Ki Lee
Bong-Ki Lee
SASung Gyun Ahn
Sung Gyun Ahn
YYYoung Jin Youn
Young Jin Youn
JLJae-Hwan Lee
Jae-Hwan Lee
Distal radial access (DRA) has emerged as an alternative to transradial access (TRA) in coronary procedures. However, evidence supporting its use in ST-segment elevation myocardial infarction (STEMI) remains limited. The purpose of this study was to assess whether DRA is noninferior to TRA in patients undergoing primary percutaneous coronary intervention (PCI) for STEMI. This multicenter, open-label, randomized controlled trial was conducted at 3 centers in South Korea. Patients undergoing primary PCI for STEMI were randomly assigned to either the DRA or TRA group. The primary endpoint was the puncture success rate. A noninferiority testing with a prespecified margin of 5.65% was performed in the intention-to-treat, per-protocol, and as-treated populations (NCT03611725). From August 2018 to February 2023, 354 patients were randomized to DRA (n = 176) or TRA (n = 178). The primary endpoint, puncture success rate was 94.3% in DRA and 96.1% in TRA (difference −1.75%; 95% CI −6.20% to 2.71%) in the intention-to-treat analysis. The per-protocol analysis also failed to demonstrate noninferiority (difference −1.72%; 95% CI -5.99% to 2.54%). DRA demonstrated noninferiority to TRA in the as-treated population (difference −1.17%; 95% CI -5.56% to 3.22%). The rates of successful coronary angiography and PCI, access-site crossover, and bleeding complications were comparable between groups. One radial artery occlusion occurred in TRA group at 1-month follow-up. In STEMI patients, DRA failed to demonstrate noninferiority to TRA in terms of puncture success. However, both access routes showed comparable procedural efficacy and safety. Further validation with a larger, adequately powered study is required to confirm these findings.

1 January 2024 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
JLJung-Hee Lee
Jung-Hee Lee
SASung Gyun Ahn
Sung Gyun Ahn
HJHo Sung Jeon
Ho Sung Jeon
YYYoung Jin Youn
Young Jin Youn
JZJinlong Zhang
Jinlong Zhang
BKBon-Kwon Koo
Bon-Kwon Koo
Lee JH, et al. Korean Circ J. 2024 Jun;54:e69. https://doi.org/10.4070/kcj.2024.0046

1 January 2024 in Journal of Cardiovascular Intervention
Verified
Journal Article
Open access
PDF file
HJHo Sung Jeon
Ho Sung Jeon
JLJung-Hee Lee
Jung-Hee Lee
JSJung-Woo Son
Jung-Woo Son
YYYoung Jin Youn
Young Jin Youn
SASung Gyun Ahn
Sung Gyun Ahn
Jeon HS, et al. J Cardiovasc Interv. 2024 Jan;3(1):23-28. https://doi.org/10.54912/jci.2023.0017

1 January 2025 in Journal of Cardiovascular Intervention
Verified
Journal Article
Open access
PDF file
SASung Gyun Ahn
Sung Gyun Ahn
HJHo Sung Jeon
Ho Sung Jeon
JPJae Hyung Park
Jae Hyung Park
JSJon Suh
Jon Suh
SPSang Min Park
Sang Min Park
SKSang-Hyun Kim
Sang-Hyun Kim
Ahn SG, et al. J Cardiovasc Interv. 2025 May;4:e21. https://doi.org/10.54912/jci.2025.0011